Institutional investors purchased a net $4.8 million shares of MDCO during the quarter ended December 2017 and now own 132.95% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAMBER CAPITAL MANAGEMENT LLC Bought 1.6 Million shares of Medicines Co
GREENLIGHT CAPITAL, INC. Bought 1.0 Million shares of Medicines Co
THREE BAYS CAPITAL LP Bought 979.9 Thousand shares of Medicines Co